181 related articles for article (PubMed ID: 18473831)
1. Trypanosomiais and leishmaniasis "recent development in the chemotherapy of infectious diseases caused by parasitic protozoa".
de Souza W
Curr Pharm Des; 2008; 14(9):821. PubMed ID: 18473831
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of leishmaniasis and human trypanosomiasis: status and new developments].
Kayser O; Croft SL; Kolodziej H
Pharm Unserer Zeit; 1999 Jul; 28(4):177-85. PubMed ID: 10443145
[No Abstract] [Full Text] [Related]
3. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.
Nagle AS; Khare S; Kumar AB; Supek F; Buchynskyy A; Mathison CJ; Chennamaneni NK; Pendem N; Buckner FS; Gelb MH; Molteni V
Chem Rev; 2014 Nov; 114(22):11305-47. PubMed ID: 25365529
[No Abstract] [Full Text] [Related]
4. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
Pershin GN; Moskalenko NIu
Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
[No Abstract] [Full Text] [Related]
5. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
Fournet A; Muñoz V
Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
[TBL] [Abstract][Full Text] [Related]
6. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
[TBL] [Abstract][Full Text] [Related]
7. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
Rodrigues JC; de Souza W
Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
[TBL] [Abstract][Full Text] [Related]
9. Microorganisms as a Potential Source of Molecules to Control Trypanosomatid Diseases.
Chan-Bacab MJ; Reyes-Estebanez MM; Camacho-Chab JC; Ortega-Morales BO
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806654
[TBL] [Abstract][Full Text] [Related]
10. 'Exotic' parasitic infections: recent progress in diagnosis and management.
Cook GC
J Infect; 1990 Mar; 20(2):95-102. PubMed ID: 2319160
[No Abstract] [Full Text] [Related]
11. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
Navarro M; Gabbiani C; Messori L; Gambino D
Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.
Pacheco PAF; Santos MMM
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011552
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of trypanosomiases and leishmaniasis.
Croft SL; Barrett MP; Urbina JA
Trends Parasitol; 2005 Nov; 21(11):508-12. PubMed ID: 16150644
[TBL] [Abstract][Full Text] [Related]
14. Kinetoplast as a potential chemotherapeutic target of trypanosomatids.
Motta MC
Curr Pharm Des; 2008; 14(9):847-54. PubMed ID: 18473834
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and trypanosomatids: targets and drugs.
Fidalgo LM; Gille L
Pharm Res; 2011 Nov; 28(11):2758-70. PubMed ID: 21935742
[TBL] [Abstract][Full Text] [Related]
16. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
[TBL] [Abstract][Full Text] [Related]
17. Drugs for parasitic infections.
Med Lett Drugs Ther; 1986 Jan; 28(706):9-16. PubMed ID: 3945225
[No Abstract] [Full Text] [Related]
18. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
Francesconi V; Rizzo M; Schenone S; Carbone A; Tonelli M
Curr Med Chem; 2024; 31(15):1955-1982. PubMed ID: 37718524
[TBL] [Abstract][Full Text] [Related]
19. Progresses in the field of drug design to combat tropical protozoan parasitic diseases.
Liñares GE; Ravaschino EL; Rodriguez JB
Curr Med Chem; 2006; 13(3):335-60. PubMed ID: 16475941
[TBL] [Abstract][Full Text] [Related]
20. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
Njogu PM; Guantai EM; Pavadai E; Chibale K
ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
